Back

SGLT2i for HFpEF - rebuttal and discussion.

23 May 2022 (09:10 - 09:30)
Organised by:
Congress Presentation Part of: SGLT2i for HFpEF Chronic Heart Failure HFA Premium Access Heart Failure 2022

2 More presentations in this session

Presentation thumbnail
SGLT2i is indicated for all HFpEF patients - pro.
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
SGLT2i is indicated for all HFpEF patients - con.
Professor S. Harikrishnan (Thiruvananthapuram, IN)
Slides Video

Access the full session

Session thumbnail
SGLT2i for HFpEF
Video

The Event

Event poster

Heart Failure 2022

23 May 2022 09:10 CET
You may be interested in
thumbnail
Congress Session
SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice
23 May 2022
thumbnail
Congress Session
How to treat HFpEF in 2022 and beyond
29 August 2022
thumbnail
Congress Session
Further Insights into SGLT2i treatment for heart failure
31 August 2024
thumbnail
Congress Session
Great Debate: controversies in the contemporary management of HFrEF
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources